BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells.
BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells.
复制标题
BMP 信号传导诱导临床来源的少突神经胶质瘤增殖细胞的星形胶质细胞分化。
DOI:
10.1158/1541-7786.mcr-13-0349
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Kessler,JohnA
中科院分区:
文献类型:
--
作者:
Srikanth,Maya;Kim,Juno;Das,Sunit;Kessler,JohnA
Oligodendrogliomas are a type of glioma that lack detailed investigation because of an inability to cultivate oligodendroglioma cells that faithfully recapitulate their salient qualities. We have successfully isolated and propagated glioma stem-like cells from multiple clinical oligodendroglioma specimens. These oligodendroglioma-propagating cells (OligPC) are multipotent and form xenografts with oligodendroglioma features. Bone morphogenetic proteins (BMP) are considered potent inhibitors of oligodendrogliogenesis during development; therefore, the effects of BMP signaling in OligPCs were characterized. BMP pathway components are expressed by OligPCs and canonical signaling via Smad proteins is intact. This signaling potently depletes CD133-positive OligPCs, decreasing proliferation, and inducing astrocytic differentiation. Furthermore, analyses revealed that cytoplasmic sequestration of the oligodendrocyte differentiation factors OLIG1/2 by the BMP signaling effectors ID2 and ID4 is a plausible underlying mechanism. These findings elucidate the molecular pathways that underlie the effects of BMP signaling on oligodendroglioma stem-like cells.Implications:Stem-like cells are capable of propagating oligodendrogliomas, and BMP signaling potently diminishes their stemness by inducing astrocytic differentiation, suggesting that BMP activation may be effective as a cancer stem cell–targeted therapy.Mol Cancer Res; 12(2); 283–94. ©2013 AACR.